{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:19:39Z","timestamp":1768717179983,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003827","name":"Nemzeti Kutat\u00e1si \u00e9s Technol\u00f3giai Hivatal","doi-asserted-by":"publisher","award":["KTIA_NAP_ 2017-1.2.1-NKP-2017-00002"],"award-info":[{"award-number":["KTIA_NAP_ 2017-1.2.1-NKP-2017-00002"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis Egyetem","doi-asserted-by":"publisher","award":["EFOP-3.6.3-VEKOP-16-2017-00009"],"award-info":[{"award-number":["EFOP-3.6.3-VEKOP-16-2017-00009"]}],"id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Parkinsonism is a complex multifactorial neurodegenerative disorder, in which genetic and environmental risk factors may both play a role. Among environmental risk factors cocaine was earlier ambiguously linked to Parkinsonism. Former single case reports described Parkinsonism in chronic cocaine users, but an epidemiological study did not confirm an increased risk of Parkinson\u2019s disease. Here we report a patient, who developed Parkinsonism in young age after chronic cocaine use, in whom a homozygous <jats:italic>LRRK2<\/jats:italic> risk variant was also detected.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient was investigated because of hand tremor, which started after a 1.5-year period of cocaine abuse. Neurological examination suggested Parkinsonism, and asymmetrical pathology was confirmed by the dopamine transporter imaging study. The genetic investigations revealed a homozygous risk allele in the <jats:italic>LRRK2<\/jats:italic> gene. After a period of cocaine abstinence, the patient\u2019s symptoms spontaneously regressed, and the dopamine transporter imaging also returned to near-normal.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case report suggests that cocaine abuse indeed might be linked to secondary Parkinsonism and serves as an example of a potential gene-environmental interaction between the detected LRRK2 risk variant and cocaine abuse. The reversible nature of the DaTscan pathology is a unique feature of this case, and needs further evaluation, whether this is incidental or can be a feature of cocaine related Parkinsonism.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-019-1496-y","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T12:04:38Z","timestamp":1572264278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dynamic interaction of genetic risk factors and cocaine abuse in the background of Parkinsonism \u2013 a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Anett","family":"Ill\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Balicza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e1ta","family":"Bencsik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Szilv\u00e1si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-1864","authenticated-orcid":false,"given":"Maria Judit","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"issue":"9","key":"1496_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","volume":"34","author":"RA Vaughan","year":"2013","unstructured":"Vaughan RA, Foster JD. Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol Sci. 2013;34(9):489\u201396 [cited 2018 Jul 6] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23968642\n                    \n                  .","journal-title":"Trends Pharmacol Sci"},{"key":"1496_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fnbeh.2014.00303","volume":"8","author":"T Ueno","year":"2014","unstructured":"Ueno T, Kume K. Functional characterization of dopamine transporter in vivo using Drosophila melanogaster behavioral assays. Front Behav Neurosci. 2014;8:303 [cited 2018 Aug 15] Available from: \n                    http:\/\/journal.frontiersin.org\/article\/10.3389\/fnbeh.2014.00303\/abstract\n                    \n                  .","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"1496_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1874473711205030243","volume":"5","author":"A Deik","year":"2012","unstructured":"Deik A, Saunders-Pullman R, Luciano MS. Substance of abuse and movement disorders: complex interactions and comorbidities. Curr Drug Abuse Rev. 2012;5(3):243\u201353 [cited 2018 Aug 15] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23030352\n                    \n                  .","journal-title":"Curr Drug Abuse Rev"},{"issue":"9","key":"1496_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","volume":"34","author":"RA Vaughan","year":"2013","unstructured":"Vaughan RA, Foster JD. Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol Sci. 2013;34(9):489\u201396 [cited 2018 May 23] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23968642\n                    \n                  .","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"1496_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.9758\/cpn.2015.13.3.227","volume":"13","author":"V Verma","year":"2015","unstructured":"Verma V. Classic Studies on the Interaction of Cocaine and the Dopamine Transporter. Clin Psychopharmacol Neurosci. 2015;13(3):227\u201338 [cited 2018 May 23] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26598579\n                    \n                  .","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"3","key":"1496_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.neuroscience.2005.09.035","volume":"137","author":"SA Lloyd","year":"2006","unstructured":"Lloyd SA, Faherty CJ, Smeyne RJ. Adult and in utero exposure to cocaine alters sensitivity to the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 2006;137(3):905\u201313 [cited 2018 Aug 15] Available from: \n                    https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S030645220501095X\n                    \n                  .","journal-title":"Neuroscience"},{"key":"1496_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugalcdep.2014.10.027","volume":"146","author":"K Curtin","year":"2015","unstructured":"Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR. Methamphetamine\/amphetamine abuse and risk of Parkinson\u2019s disease in Utah: a population-based assessment. Drug Alcohol Depend. 2015;146:30\u20138 [cited 2018 Aug 15] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25479916\n                    \n                  .","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"1496_CR8","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1021\/acschemneuro.5b00172","volume":"6","author":"J Kakish","year":"2015","unstructured":"Kakish J, Lee D, Lee JS. Drugs That Bind to \u03b1-Synuclein: Neuroprotective or Neurotoxic? ACS Chem Neurosci. 2015;6(12):1930\u201340 [cited 2018 Sep 23] Available from: \n                    http:\/\/pubs.acs.org\/doi\/10.1021\/acschemneuro.5b00172\n                    \n                  .","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"1496_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211 [cited 2018 Aug 15] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12498954\n                    \n                  .","journal-title":"Neurobiol Aging"},{"issue":"13","key":"1496_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1097\/01.wnr.0000175617.39054.ba","volume":"16","author":"Y Qin","year":"2005","unstructured":"Qin Y, Ouyang Q, Pablo J, Mash DC. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport. 2005;16(13):1489\u201393 [cited 2018 Sep 23] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16110277\n                    \n                  .","journal-title":"Neuroreport"},{"issue":"6","key":"1496_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","volume":"30","author":"CM Lill","year":"2016","unstructured":"Lill CM. Genetics of Parkinson\u2019s disease. Mol Cell Probes. 2016;30(6):386\u201396.","journal-title":"Mol Cell Probes"},{"issue":"2","key":"1496_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","volume":"37","author":"J Darcourt","year":"2010","unstructured":"Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu \u00d6L, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37(2):443\u201350 [cited 2019 Jun 12] Available from: \n                    http:\/\/link.springer.com\/10.1007\/s00259-009-1267-x\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1496_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.27121","volume":"33","author":"KP Bhatia","year":"2018","unstructured":"Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018;33(1):75\u201387 [cited 2018 Aug 17] Available from: \n                    http:\/\/doi.wiley.com\/10.1002\/mds.27121\n                    \n                  .","journal-title":"Mov Disord"},{"issue":"1","key":"1496_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","volume":"81","author":"G Kagi","year":"2010","unstructured":"Kagi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81(1):5\u201312 [cited 2019 Jun 16] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20019219\n                    \n                  .","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1496_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00259-012-2276-8","volume":"40","author":"A Varrone","year":"2013","unstructured":"Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2013;40(2):213\u201327 [cited 2019 Jun 12] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23160999\n                    \n                  .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1496_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1468-1331.2010.03164.x","volume":"18","author":"Y Zheng","year":"2011","unstructured":"Zheng Y, Liu Y, Wu Q, Hong H, Zhou H, Chen J, et al. Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson\u2019s disease in Southern China. Eur J Neurol. 2011;18(3):538\u201340 [cited 2018 Apr 2] Available from: \n                    http:\/\/doi.wiley.com\/10.1111\/j.1468-1331.2010.03164.x\n                    \n                  .","journal-title":"Eur J Neurol"},{"issue":"30","key":"1496_CR17","doi-asserted-by":"publisher","first-page":"7807","DOI":"10.1523\/JNEUROSCI.4652-15.2016","volume":"36","author":"CA Siciliano","year":"2016","unstructured":"Siciliano CA, Fordahl SC, Jones SR. Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine. J Neurosci. 2016;36(30):7807\u201316 [cited 2019 Aug 24] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27466327\n                    \n                  .","journal-title":"J Neurosci"},{"issue":"2","key":"1496_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1365-2990.2010.01131.x","volume":"37","author":"A B\u00fcttner","year":"2011","unstructured":"B\u00fcttner A. Review: The neuropathology of drug abuse. Neuropathol Appl Neurobiol. 2011;37(2):118\u201334 [cited 2018 Aug 15] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20946118\n                    \n                  .","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1496_CR19","unstructured":"Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, Laruelle M, et al. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry. 1998;(6):155, 832\u20134 [cited 2018 Sep 23] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9619159\n                    \n                  ."},{"issue":"7","key":"1496_CR20","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1530-0277.1996.tb01111.x","volume":"20","author":"LO Bauer","year":"1996","unstructured":"Bauer LO. Resting hand tremor in abstinent cocaine-dependent, alcohol-dependent, and polydrug-dependent patients. Alcohol Clin Exp Res. 1996;20(7):1196\u2013201 [cited 2018 Aug 15] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8904970\n                    \n                  .","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"1496_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/syn.890140210","volume":"14","author":"ND Volkow","year":"1993","unstructured":"Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993;14(2):169\u201377 [cited 2018 Sep 23] Available from: \n                    http:\/\/doi.wiley.com\/10.1002\/syn.890140210\n                    \n                  .","journal-title":"Synapse"},{"key":"1496_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fneur.2015.00075","volume":"6","author":"A Asser","year":"2015","unstructured":"Asser A, Taba P. Psychostimulants and movement disorders. Front Neurol. 2015;6:75 [cited 2018 Sep 23] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25941511\n                    \n                  .","journal-title":"Front Neurol"},{"key":"1496_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.06.041","volume":"142","author":"L Sordo","year":"2014","unstructured":"Sordo L, Indave BI, Barrio G, Degenhardt L, de la Fuente L, Bravo MJ. Cocaine use and risk of stroke: a systematic review. Drug Alcohol Depend. 2014;142:1\u201313 [cited 2018 Sep 23] Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614009685\n                    \n                  .","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1496_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0925-4927(99)00052-9","volume":"98","author":"G Bartzokis","year":"2000","unstructured":"Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, et al. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res. 2000;98(2):93\u2013102 [cited 2018 Sep 23] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10762735\n                    \n                  .","journal-title":"Psychiatry Res"},{"issue":"1","key":"1496_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pscychresns.2009.07.004","volume":"181","author":"MJ Romero","year":"2010","unstructured":"Romero MJ, Asensio S, Palau C, Sanchez A, Romero FJ. Cocaine addiction: diffusion tensor imaging study of the inferior frontal and anterior cingulate white matter. Psychiatry Res. 2010;181(1):57\u201363 [cited 2018 Sep 23] Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492709001693\n                    \n                  .","journal-title":"Psychiatry Res"},{"issue":"6","key":"1496_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/01.jcp.0000245564.44778.d1","volume":"26","author":"A Di Rocco","year":"2006","unstructured":"Di Rocco A, Nasser S, Werner P. Inhaled Cocaine Used to Relieve &quot;Off&quot; Periods in Patients With Parkinson Disease and Unpredictable Motor Fluctuations. J Clin Psychopharmacol. 2006;26(6):689\u201390 [cited 2018 Sep 23] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17110842\n                    \n                  .","journal-title":"J Clin Psychopharmacol"},{"issue":"1\u20133","key":"1496_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","volume":"120","author":"RC Callaghan","year":"2012","unstructured":"Callaghan RC, Cunningham JK, Sykes J, Kish SJ. Increased risk of Parkinson\u2019s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend. 2012;120(1\u20133):35\u201340 [cited 2018 Aug 15] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21794992\n                    \n                  .","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1496_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3109\/00207454.2012.732976","volume":"123","author":"TT Lim","year":"2013","unstructured":"Lim TT, Ahmed A, Itin I, Gostkowski M, Rudolph J, Cooper S, et al. Is 6 Months of Neuroleptic Withdrawal Sufficient to Distinguish Drug-Induced Parkinsonism From Parkinson\u2019s Disease? Int J Neurosci. 2013;123(3):170\u20134 [cited 2019 Aug 25] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23078283\n                    \n                  .","journal-title":"Int J Neurosci"},{"issue":"6","key":"1496_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/mds.26209","volume":"30","author":"R Erro","year":"2015","unstructured":"Erro R, Bhatia KP, Tinazzi M. Parkinsonism following neuroleptic exposure: A double-hit hypothesis? Mov Disord. 2015;30(6):780\u20135 [cited 2019 Aug 25] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25801826\n                    \n                  .","journal-title":"Mov Disord"},{"issue":"2","key":"1496_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.parkreldis.2010.11.011","volume":"17","author":"C-HH Lin","year":"2011","unstructured":"Lin C-HH, Wu R-MM, Tai C-HH, Chen M-LL, Hu F-CC. Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson\u2019s disease. Park Relat Disord. 2011;17(2):84\u20138 [cited 2019 May 24] Available from: \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2010.11.011\n                    \n                  .","journal-title":"Park Relat Disord"},{"key":"1496_CR31","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S1353-8020(11)70021-9","volume":"18","author":"T Peeraully","year":"2012","unstructured":"Peeraully T, Tan EK. Genetic variants in Sporadic Parkinson\u2019s Disease: East vs West. Park Relat Disord. 2012;18:S63\u20135 [cited 2019 May 24] Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22166457\n                    \n                  .","journal-title":"Park Relat Disord"},{"issue":"3","key":"1496_CR32","doi-asserted-by":"publisher","first-page":"e0148373","DOI":"10.1371\/journal.pone.0148373","volume":"11","author":"Brett C. Haberstick","year":"2016","unstructured":"Haberstick BC, Boardman JD, Wagner B, Smolen A, Hewitt JK, Killeya-Jones LA, et al. Depression, Stressful Life Events, and the Impact of Variation in the Serotonin Transporter: Findings from the National Longitudinal Study of Adolescent to Adult Health (Add Health). PLoS One. 2016;11(3). [cited 2019 Jun 12] Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4777542\/","journal-title":"PLOS ONE"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1496-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1496-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1496-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:05:33Z","timestamp":1603757133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1496-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1496-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript is a retrospective case study, it has an institutional ethical committee approval. The study was performed in accordance with the declaration of Helsinki.The Hungarian Research Ethics Committee approved the study. Approval number is: 44599\u20132\/2013\/EKU (535\/2013.) The patient\u2019s gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent for genetic testing and the use of the data for scientific publication was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}